NO920261D0 - Kontrastmedier - Google Patents

Kontrastmedier

Info

Publication number
NO920261D0
NO920261D0 NO1992920261A NO920261A NO920261D0 NO 920261 D0 NO920261 D0 NO 920261D0 NO 1992920261 A NO1992920261 A NO 1992920261A NO 920261 A NO920261 A NO 920261A NO 920261 D0 NO920261 D0 NO 920261D0
Authority
NO
Norway
Prior art keywords
contrast media
water soluble
containing substance
metal species
physiologically tolerable
Prior art date
Application number
NO1992920261A
Other languages
English (en)
Other versions
NO302797B1 (no
NO920261L (no
Inventor
Jo Klaveness
Original Assignee
Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed As filed Critical Nycomed As
Publication of NO920261D0 publication Critical patent/NO920261D0/no
Publication of NO920261L publication Critical patent/NO920261L/no
Publication of NO302797B1 publication Critical patent/NO302797B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0495Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/806Electrical property or magnetic property
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/24Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Steroid Compounds (AREA)
  • Liquid Crystal (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
NO920261A 1989-07-21 1992-01-20 Kontrastmedier og anvendelse NO302797B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898916781A GB8916781D0 (en) 1989-07-21 1989-07-21 Compositions
PCT/EP1990/001197 WO1991001149A1 (en) 1989-07-21 1990-07-19 Contrast media

Publications (3)

Publication Number Publication Date
NO920261D0 true NO920261D0 (no) 1992-01-20
NO920261L NO920261L (no) 1992-01-20
NO302797B1 NO302797B1 (no) 1998-04-27

Family

ID=10660460

Family Applications (1)

Application Number Title Priority Date Filing Date
NO920261A NO302797B1 (no) 1989-07-21 1992-01-20 Kontrastmedier og anvendelse

Country Status (13)

Country Link
US (1) US5242683A (no)
EP (2) EP0414288B1 (no)
JP (1) JP3054660B2 (no)
AT (1) ATE103183T1 (no)
AU (1) AU641422B2 (no)
CA (1) CA2055604A1 (no)
DE (1) DE69007575T2 (no)
DK (1) DK0414288T3 (no)
ES (1) ES2052161T3 (no)
FI (1) FI98988C (no)
GB (1) GB8916781D0 (no)
NO (1) NO302797B1 (no)
WO (1) WO1991001149A1 (no)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114703A (en) * 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
GB8916782D0 (en) * 1989-07-21 1989-09-06 Nycomed As Compositions
US5547682A (en) * 1989-12-22 1996-08-20 Bioquest, Incorporated Preparation and use of novel injectable RES avoiding inorganic particles for medical application
DE4115789A1 (de) * 1991-05-10 1992-11-12 Schering Ag Makrocyclische polymer-komplexbildner, deren komplexe, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
ATE195432T1 (de) * 1993-06-02 2000-09-15 Bracco Spa Iodierte paramagnetische chelaten, und deren verwendung als kontrastmittel
US6162192A (en) 1998-05-01 2000-12-19 Sub Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US6183497B1 (en) 1998-05-01 2001-02-06 Sub-Q, Inc. Absorbable sponge with contrasting agent
US6071301A (en) 1998-05-01 2000-06-06 Sub Q., Inc. Device and method for facilitating hemostasis of a biopsy tract
US6071300A (en) 1995-09-15 2000-06-06 Sub-Q Inc. Apparatus and method for percutaneous sealing of blood vessel punctures
DE19641197C2 (de) * 1996-09-24 1999-02-18 Schering Ag Ionenpaare und ihre Verwendung als Kontrastmittel
FR2772025B1 (fr) * 1997-12-10 2000-03-03 Guerbet Sa Chelates metalliques de macrocycles polyaminocarboxyliques et leur application a l'imagerie par resonance magnetique
US6610026B2 (en) 1998-05-01 2003-08-26 Sub-Q, Inc. Method of hydrating a sponge material for delivery to a body
US20010045575A1 (en) 1998-05-01 2001-11-29 Mark Ashby Device and method for facilitating hemostasis of a biopsy tract
US6200328B1 (en) 1998-05-01 2001-03-13 Sub Q, Incorporated Device and method for facilitating hemostasis of a biopsy tract
US6315753B1 (en) 1998-05-01 2001-11-13 Sub-Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US7625352B1 (en) 1998-05-01 2009-12-01 Sub-Q, Inc. Depth and puncture control for system for hemostasis of blood vessel
CA2361564A1 (en) 1999-02-10 2000-08-17 Mark Ashby Device and method for facilitating hemostasis of a biopsy tract
US6984219B2 (en) 1999-09-23 2006-01-10 Mark Ashby Depth and puncture control for blood vessel hemostasis system
US7695492B1 (en) 1999-09-23 2010-04-13 Boston Scientific Scimed, Inc. Enhanced bleed back system
US6540735B1 (en) 2000-05-12 2003-04-01 Sub-Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US7201725B1 (en) 2000-09-25 2007-04-10 Sub-Q, Inc. Device and method for determining a depth of an incision
US8187625B2 (en) 2001-03-12 2012-05-29 Boston Scientific Scimed, Inc. Cross-linked gelatin composition comprising a wetting agent
WO2002087636A1 (en) 2001-03-12 2002-11-07 Sub-Q, Inc. Methods for sterilizing cross-linked gelatin compositions
US6584355B2 (en) * 2001-04-10 2003-06-24 Cardiac Pacemakers, Inc. System and method for measuring battery current
US7029489B1 (en) 2001-05-18 2006-04-18 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture site
US7008440B2 (en) 2001-11-08 2006-03-07 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US6863680B2 (en) * 2001-11-08 2005-03-08 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US7037322B1 (en) 2001-11-08 2006-05-02 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture with a staging tube
US7037323B2 (en) 2001-11-08 2006-05-02 Sub-Q, Inc. Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US7192436B2 (en) 2001-11-08 2007-03-20 Sub-Q, Inc. Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
EP1523307A1 (de) * 2002-07-19 2005-04-20 Mestex AG Verwendung von neurotoxischen substanzen für die herstellung eines mittels zur behandlung von gelenkschmerzen und verfahren zur applikation dieses mittels
US20040102730A1 (en) * 2002-10-22 2004-05-27 Davis Thomas P. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US7955353B1 (en) 2002-11-04 2011-06-07 Sub-Q, Inc. Dissolvable closure device
US7455680B1 (en) 2002-11-04 2008-11-25 Boston Scientific Scimed, Inc. Apparatus and method for inhibiting blood loss
US8317821B1 (en) 2002-11-04 2012-11-27 Boston Scientific Scimed, Inc. Release mechanism
US20050180920A1 (en) * 2003-01-29 2005-08-18 Vincenzo Giuliano Oral contrast media composition for computerized axial tomographic examinations and method
US7378081B2 (en) * 2003-01-29 2008-05-27 Vincon Research Enterprises, Llc Composition and method for direct visualization of the human appendix
US20040265235A1 (en) * 2003-06-26 2004-12-30 Uzgiris Egidijus Edward Magnetic resonance contrast-enhancing agents and method for detecting and imaging artherosclerotic plaque
US7875043B1 (en) 2003-12-09 2011-01-25 Sub-Q, Inc. Cinching loop
WO2006068639A1 (en) * 2004-12-21 2006-06-29 Vincenzo Giuliano Oral contrast media composition for computerized axial tomographic examinations and method
US7384624B2 (en) * 2004-12-27 2008-06-10 James Raines Oral contrast and method of producing the oral contrast
AU2005321543A1 (en) * 2004-12-30 2006-07-06 Cinvention Ag Combination comprising an agent providing a signal, an implant material and a drug
SI1836239T1 (sl) * 2005-01-13 2009-04-30 Cinv Ag Kompozitni materiali, ki vsebujejo ogljikove nanodelce
EP1848464B1 (en) * 2005-02-11 2014-04-23 University Health Network Compositions and methods for multimodal imaging
KR20070120158A (ko) * 2005-03-18 2007-12-21 신벤션 아게 다공성 소결 금속 물질의 제조 방법
CN101212990A (zh) * 2005-07-01 2008-07-02 金文申有限公司 包含网状复合材料的医疗器械
BRPI0617450A2 (pt) * 2005-10-18 2011-07-26 Cinv Ag partÍculas de termocura e mÉtodos para produÇço das mesmas
ATE494916T1 (de) * 2006-05-26 2011-01-15 Baxter Int Injizierbarer füllstoff für knochenhohlräume
DK2029184T3 (da) 2006-05-26 2011-05-02 Baxter Int Injicerbar fibrinsammensætning til knogleforstærkning
US8601223B1 (en) 2006-09-19 2013-12-03 Nvidia Corporation Techniques for servicing fetch requests utilizing coalesing page table entries
ATE542552T1 (de) 2007-03-26 2012-02-15 Baxter Int Injizierbarer hohlraumfüller für weichgewebevergrösserung
WO2012007456A1 (en) * 2010-07-12 2012-01-19 Ge Healthcare As X-ray imaging at low contrast agent concentrations and/or low dose radiation
EP2802357A1 (en) * 2012-01-11 2014-11-19 Ge Healthcare As X-ray imaging contrast media with low iodine concentration and x-ray imaging process
PT3076947T (pt) * 2013-12-04 2018-10-17 Hovione Scientia Ltd Meios de contraste contendo formulações para mascarar o sabor

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2387735A (en) * 1941-07-03 1945-10-30 Martin Dennis Company Method of forming carboxylic amino acids
US2407645A (en) * 1943-06-21 1946-09-17 Martin Dennis Company Aliphatic polycarboxylic amino acids and process of making them
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3316703A1 (de) * 1983-05-04 1984-11-08 Schering AG, 1000 Berlin und 4709 Bergkamen Orales kontrastmittel fuer die kernspintomographie und dessen herstellung
DE3324235A1 (de) * 1983-07-01 1985-01-10 Schering AG, 1000 Berlin und 4709 Bergkamen Neue komplexbildner, komplexe und komplexsalze
US4615879A (en) * 1983-11-14 1986-10-07 Vanderbilt University Particulate NMR contrast agents for gastrointestinal application
US5013831A (en) * 1984-01-30 1991-05-07 Enzo Biochem, Inc. Detectable molecules, method of preparation and use
GB8413772D0 (en) * 1984-05-30 1984-07-04 Nyegaard & Co As Chemical compounds
US4639365A (en) * 1984-10-18 1987-01-27 The Board Of Regents, The University Of Texas System Gadolinium chelates as NMR contrast agents
SE465907B (sv) * 1984-11-01 1991-11-18 Nyegaard & Co As Diagnosticeringsmedel innehaallande en paramagnetisk metall
EP0184899B1 (en) * 1984-11-01 1990-04-18 Nycomed As Paramagnetic contrast agents for use in "in vivo" diagnostic methods using nmr, and their preparation
US4826673A (en) * 1985-01-09 1989-05-02 Mallinckrodt, Inc. Methods and compositions for enhancing magnetic resonance imaging
US4880008A (en) * 1985-05-08 1989-11-14 The General Hospital Corporation Vivo enhancement of NMR relaxivity
NZ212437A (en) * 1985-06-17 1992-06-25 Mark Philip Best Site-directed antibody conjugates, and their preparation
JPS62153229A (ja) * 1985-12-27 1987-07-08 Nippon Oil Co Ltd 皮膚マ−カ−
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
IT1213029B (it) * 1986-01-30 1989-12-07 Bracco Ind Chimica Spa Chelati di ioni metallici paramagnetici.
US5104641A (en) * 1986-03-07 1992-04-14 M.R.I., Inc. Nitroxide NMR contrast enhancing agents and their use in NMR imaging
AU608759B2 (en) * 1986-08-04 1991-04-18 Amersham Health Salutar Inc NMR imaging with paramagnetic polyvalents metal salts of poly-(acid-alkylene-amido)-alkanes
IL83966A (en) * 1986-09-26 1992-03-29 Schering Ag Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them
DE3701665A1 (de) * 1987-01-19 1988-07-28 Schering Ag Polymer-komplexe, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
DE3709851A1 (de) * 1987-03-24 1988-10-06 Silica Gel Gmbh Adsorptions Te Nmr-diagnostische fluessigkeitszusammensetzungen
ES2086445T3 (es) * 1987-07-16 1996-07-01 Nycomed Imaging As Acidos aminocarboxilicos y sus derivados.
US5114703A (en) * 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions

Also Published As

Publication number Publication date
EP0414288B1 (en) 1994-03-23
US5242683A (en) 1993-09-07
DE69007575T2 (de) 1994-07-21
FI920238A0 (fi) 1992-01-20
DK0414288T3 (da) 1994-04-11
GB8916781D0 (en) 1989-09-06
JPH04506807A (ja) 1992-11-26
NO302797B1 (no) 1998-04-27
JP3054660B2 (ja) 2000-06-19
EP0473729A1 (en) 1992-03-11
DE69007575D1 (de) 1994-04-28
ES2052161T3 (es) 1994-07-01
ATE103183T1 (de) 1994-04-15
AU641422B2 (en) 1993-09-23
WO1991001149A1 (en) 1991-02-07
FI98988B (fi) 1997-06-13
FI98988C (fi) 1997-09-25
EP0414288A1 (en) 1991-02-27
CA2055604A1 (en) 1991-01-22
AU6143890A (en) 1991-02-22
NO920261L (no) 1992-01-20

Similar Documents

Publication Publication Date Title
NO920261L (no) Kontrastmedier
DE3582197D1 (de) Wirksamkeitsmessung eines lithographischen apparates.
NZ230778A (en) Diagnostic imaging contrast medium comprising biscarbamoyl derivatives
ES2048417T3 (es) Medios de contraste en particulas.
FR2517099B1 (fr) Support d'enregistrement magnetique
JPS57102285A (en) Use of amino-phenol as oxygen removing agent in aqueous medium
DE3163087D1 (en) Radioactive diagnostic agent for bone scanning and non-radioactive carrier therefor
DE59006585D1 (de) Nichtionisches Röntgenkontrastmittel mit hohem Jodgehalt.
NZ234574A (en) A contrast medium containing magnetically responsive particles and viscosity enhancing agent; use in magnetic resonance imaging
GB9018974D0 (en) Developer material for use with recording of photosensitive medium
GB8818858D0 (en) Clutch & brake apparatus operable by compressible fluid
ZA826034B (en) Bromobenzene compounds useful in x-ray contrast media
ZA893866B (en) Novel iodinated non-ionic triiodobenzene compounds and contrast media containing them
FR2645317B1 (fr) Milieu d'enregistrement magnetique
GB2103409B (en) Optically readable record carrier and read apparatus therefore
IT8324186A0 (it) Procedimento per la tempra in mezzo acquoso di leghe ferrose.
ZA826032B (en) Iodo-bromo-benzene compounds and x-ray contrast media containing same
JPS56163682A (en) Preparing device for "go" record code for printing
EP0428946A3 (en) Magneto-optic recording medium
DE3875274D1 (de) Pulverfoermige substanz zur reibungsverminderung des aufnahmetraegers eines magnetischen druckers.
IT8423620A0 (it) Apparecchio per il trattamento di pellicole radiografiche per uso dentario e procedimento per ottenere un'immagine radiografica dentaria.
IT8224718A0 (it) Inchiostro per stampa planografica senza l'impiego di una soluzione sorgente e metodo per il suo impiego.
ATA45091A (de) Hülsenlose patrone
PT69400A (en) Triiodophenyl-aminopropionic acids and x-ray contrast media comprising the same our code
NO161310C (no) Fremgangsmaate og anordning for utsetting og opptaging av et legeme i sjoeen.